Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Becker

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
Nature Nanotechnology|March 27, 2019
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levelsVicenta Trujillo-Alonso, Edwin C Pratt, Hongliang Zong, et al.
Blood Advances|December 9, 2025
Elevated Lactate in AML Bone Marrow Contributes to Macrophage Polarization via GPR81 SignalingCelia A Soto, Maggie L Lesch, Jennifer L Becker, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Temporal Single Cell Analysis of Leukemia Microenvironment Identifies Taurine-Taurine Transporter Axis as a Key Regulator of Myeloid LeukemiaBenjamin J Rodems, Sonali Sharma, Cameron D Baker, et al.
Blood Advances|November 9, 2020
Decisional involvement and information preferences of patients with hematologic malignanciesKah Poh Loh, Mazie Tsang, Thomas W LeBlanc, et al.
Haematologica|March 11, 2017
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1Maura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, et al.
Blood Advances|September 15, 2021
Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromesMarissa LoCastro, Andrea M Baran, Jane L Liesveld, et al.
Cell Death & Disease|July 14, 2023
Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodelingEmily R Quarato, Noah A Salama, Allison J Li, et al.
Blood|December 6, 2015
Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndromeSophia R Balderman, Allison J Li, Corey M Hoffman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotectionGordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
Nature Nanotechnology|March 27, 2019
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levelsVicenta Trujillo-Alonso, Edwin C Pratt, Hongliang Zong, et al.
Blood Advances|December 9, 2025
Elevated Lactate in AML Bone Marrow Contributes to Macrophage Polarization via GPR81 SignalingCelia A Soto, Maggie L Lesch, Jennifer L Becker, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Temporal Single Cell Analysis of Leukemia Microenvironment Identifies Taurine-Taurine Transporter Axis as a Key Regulator of Myeloid LeukemiaBenjamin J Rodems, Sonali Sharma, Cameron D Baker, et al.
Blood Advances|November 9, 2020
Decisional involvement and information preferences of patients with hematologic malignanciesKah Poh Loh, Mazie Tsang, Thomas W LeBlanc, et al.
Haematologica|March 11, 2017
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1Maura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, et al.
Blood Advances|September 15, 2021
Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromesMarissa LoCastro, Andrea M Baran, Jane L Liesveld, et al.
Cell Death & Disease|July 14, 2023
Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodelingEmily R Quarato, Noah A Salama, Allison J Li, et al.
Blood|December 6, 2015
Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndromeSophia R Balderman, Allison J Li, Corey M Hoffman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotectionGordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
Pageof 8